Cargando…
1070. In vitro Activity of PLG0206 Against Isolates Commonly Found in Periprosthetic Joint Infections (PJI)
BACKGROUND: PLG0206 is a novel engineered cationic antimicrobial peptide being evaluated for treatment of prosthetic joint infections. In this study, the activity of PLG0206 was evaluated by broth microdilution against 104 isolates of Staphylococcus epidermidis, 53 other coagulase-negative staphyloc...
Autores principales: | Huang, David, Steckbeck, Jonathan, Pillar, Chris, Murray, Bev, Huganfel, David, Shinabanger, Dean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644086/ http://dx.doi.org/10.1093/ofid/ofab466.1264 |
Ejemplares similares
-
The Engineered Antibiotic Peptide PLG0206 Eliminates Biofilms and Is a Potential Treatment for Periprosthetic Joint Infections
por: Huang, David, et al.
Publicado: (2021) -
1040. Knee Explant Analysis (KnEA) Using PLG0206 in Periprosthetic Joint Infection (KnEA Study)
por: Huang, David, et al.
Publicado: (2021) -
Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class
por: Huang, David B., et al.
Publicado: (2022) -
Prospective Activity of PLG0206, an Engineered Antimicrobial Peptide, on Chronic Periprosthetic Joint Infection Total Knee Arthroplasty Components Ex Vivo: The Knee Explant Analysis (KnEA) Study
por: Huang, David, et al.
Publicado: (2021) -
1098. A Phase 1 Safety and Tolerability of Single Ascending Doses of a Novel Engineered Cationic Peptide, PLG0206, in Healthy Subjects
por: Huang, David, et al.
Publicado: (2021)